Cathie Wood’s ARK ETF adjusts with ABSI stock buy, ACCD sell

Published 27/02/2025, 02:04
Cathie Wood’s ARK ETF adjusts with ABSI stock buy, ACCD sell

Cathie Wood’s ARK ETFs have released their daily trades for Wednesday, February 26th, 2025, revealing a continued strategy of selective buying and selling across various sectors. The most significant transaction of the day was the purchase of 75,340 shares of ABSCI CORP (NASDAQ:ABSI) through the ARKG ETF, totaling approximately $302,866. This move comes after a similar acquisition on Tuesday, indicating a growing position in the biotech company.

Conversely, ARK ETFs also sold 24,672 shares of ACCOLADE INC (NASDAQ:ACCD) through the ARKG ETF, amounting to $171,470. This sale follows a larger divestment from the previous day, suggesting a scaling back of ARK’s investment in the healthcare technology firm.

This pattern of trades aligns with ARK’s recent activity. Earlier in the week, ARK increased its stakes in companies like COINBASE GLOBAL INC (NASDAQ:COIN) and IRIDIUM COMMUNICATIONS INC (NASDAQ:IRDM), while reducing exposure to ACCOLADE INC and DRAFTKINGS INC (NASDAQ:DKNG). The frequent trading in these stocks reflects ARK’s dynamic investment approach, adapting to market conditions and company performance.

In addition to these trades, the ARK ETFs have also shown a consistent interest in BEAM THERAPEUTICS INC (NASDAQ:BEAM), with purchases across multiple days, indicating a bullish outlook on the genetic medicines company. On the sell side, ARK has been reducing its holdings in ADAPTIVE BIOTECHNOLOGIES CORP (NASDAQ:ADPT) and ROCKET LAB USA INC (NASDAQ:RKLB), suggesting a strategic shift away from these stocks.

Investors following Cathie Wood’s ARK ETFs are witnessing an investment strategy that remains agile, with the fund’s management team actively seeking opportunities and managing risks across a range of innovative companies. As always, market participants will be watching closely to see how these trades play out in the context of ARK’s broader portfolio strategy.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.